QUESTION 1 An identical dose of medication was administered to a patient

QUESTION

QUESTION 1 An identical dose of medication was administered to a patient. The first time it was administered orally and the second time it was given intravenously. Plasma drug concentrations were measured at the same time intervals after administration of each drug’ In the following Figure, the results were graphed as log of the plasma drug concentration (Cpl versus time after administration. AUCIV is the area under the curve when the drug was given intravenously and AUCpo is the area under the curve when the drug was given orally. What information can you obtain based on the Figure? AUCI, (Q a. oral bioavailability O b. potency of the drug 0 C. extent and rate of oral absorption the drug 0 d. efficacy of the drug 0 eaandc

ANSWER

The Figure depicting the log of plasma drug concentration (Cpl) versus time after administration of the same dose of medication via two different routes, intravenous (IV) and oral (PO), provides valuable information about the pharmacokinetics of the drug. Specifically, it allows us to calculate the key pharmacokinetic parameters, including the oral bioavailability (F), the extent and rate of oral absorption, and potentially, the potency of the drug.

Here’s how we can interpret the Figure

1. Oral Bioavailability (F): Oral bioavailability refers to the fraction of the administered drug that reaches the systemic circulation unchanged after oral administration. It is a crucial parameter to assess the efficiency of oral drug absorption. In this Figure, the comparison of AUCIV (area under the curve after intravenous administration) to AUCpo (area under the curve after oral administration) provides insight into oral bioavailability. If AUCpo is significantly smaller than AUCIV, it suggests poor oral bioavailability, indicating that much of the orally administered drug did not reach the systemic circulation.

2. Extent and Rate of Oral Absorption: The shape and steepness of the curve after oral administration (AUCpo) reveal information about the rate and extent of drug absorption. A rapid rise and a higher peak in the plasma concentration curve indicate fast and extensive absorption, while a flatter curve with a delayed peak suggests slower and limited absorption.

3. Potency of the Drug: While the Figure primarily focuses on pharmacokinetics, it does not directly provide information about drug potency, which relates to the drug’s ability to produce a specific effect at a given concentration. Potency is usually assessed through dose-response curves and is not readily deduced from pharmacokinetic data.

4. Efficacy of the Drug: Similarly, the Figure does not offer insights into drug efficacy, which pertains to the maximum effect a drug can produce regardless of its concentration. Efficacy is determined through clinical trials and is beyond the scope of pharmacokinetic assessments.

In summary, the Figure allows us to assess oral bioavailability, the rate and extent of oral absorption, but does not directly provide information about drug potency or efficacy. It is a valuable tool for understanding how the route of administration influences the drug’s pharmacokinetics, guiding dosing regimens and clinical decisions.